Shire Adds Business Development Exec
This article was originally published in The Pink Sheet Daily
Barbara Deptula will assume the new position of Shire exec VP-business development Sept. 8
You may also be interested in...
Shire will begin operating out of a North American headquarters in Wayne, Pa. by the end of 2004
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
With an unrestricted label and once-daily dosing, rivaroxaban will do battle with Boehringer-Ingelheim's dabigatran, which is dosed twice a day but can claim superior efficacy to warfarin in the atrial fibrillation population.